Condition
Local Anesthetic Systemic Toxicity
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05897385Not ApplicableCompleted
Analgesic Effect of IntraPeritoneal LIGNOcaine in Gynaecological Open Surgery
NCT04807504CompletedPrimary
Ropivacaine Pharmacokinetics in ESP Blocks
NCT04498923Completed
Duration of Blockade of Peripheral Nerves With Bupivacaine Depending of the Adjuvants
NCT04562103Not ApplicableCompletedPrimary
Ropivacaine Plasma Concentration With or Without Epinephrine for Posterior Quadratus Lumborum Block
NCT01880034CompletedPrimary
Availability of Lipid Emulsion to Regional Anesthesia Programs at US Academic Anesthesia Departments
Showing all 5 trials